In this episode, you’ll hear a group of experts discussing base editing and how the technology is helping scientists engineer powerful cell therapies for various diseases including novel CAR-T therapies and hypoimmunogenic induced pluripotent stem cells. During the discussion, they will cover the merits of the Pin-point base editing platform, which introduces gene modifications without relying on double-strand DNA breaks, as well as how TotalSeq reagents, which confirm the safety and efficiency of editing with the Pin-point platform, support single cell multiomics analysis of edited cells.

This podcast is the first in a series. Don’t miss episode two From Functional Genomics to Cell Therapy: The Role of CRISPR-based Gene Editing and episode three Smart Vector Design for Improved Cell and Gene Therapies.

Podcast Guests:

Michelle Fraser, PhD
Head of Cell and Gene Therapy
Revvity

Anastasia L. Kaufman, PhD
Senior Scientist, Base Editing R&D,
Cell and Gene Therapy
Revvity

Josh Croteau, PhD
Program Manager, Strategic Partnerships & Commercialization
BioLegend (Revvity)

Produced with support from: